Go Pro

Precision Optics (POCI) Competitors

Precision Optics logo
$4.56 +0.01 (+0.22%)
As of 01:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.

POCI vs. PDEX, INFU, APYX, INGN, and RCEL

Should you buy Precision Optics stock or one of its competitors? MarketBeat compares Precision Optics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Precision Optics include Pro-Dex (PDEX), InfuSystem (INFU), Apyx Medical (APYX), Inogen (INGN), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

How does Precision Optics compare to Pro-Dex?

Precision Optics (NASDAQ:POCI) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Pro-Dex has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.61-$5.78M-$0.63N/A
Pro-Dex$66.59M2.58$8.98M$3.6214.86

Pro-Dex has a net margin of 16.08% compared to Precision Optics' net margin of -17.03%. Pro-Dex's return on equity of 22.78% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Pro-Dex 16.08%22.78%14.30%

Pro-Dex has a consensus price target of $70.00, suggesting a potential upside of 30.09%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pro-Dex
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 14.4% of Precision Optics shares are held by insiders. Comparatively, 45.9% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Precision Optics and Precision Optics both had 1 articles in the media. Pro-Dex's average media sentiment score of 0.90 beat Precision Optics' score of 0.75 indicating that Pro-Dex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pro-Dex
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Precision Optics has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market.

Summary

Pro-Dex beats Precision Optics on 13 of the 15 factors compared between the two stocks.

How does Precision Optics compare to InfuSystem?

Precision Optics (NASDAQ:POCI) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

InfuSystem has a net margin of 1.12% compared to Precision Optics' net margin of -17.03%. InfuSystem's return on equity of 2.78% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
InfuSystem 1.12%2.78%1.41%

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 14.4% of Precision Optics shares are held by company insiders. Comparatively, 10.8% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Precision Optics has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market. Comparatively, InfuSystem has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

In the previous week, InfuSystem had 1 more articles in the media than Precision Optics. MarketBeat recorded 2 mentions for InfuSystem and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.75 beat InfuSystem's score of 0.00 indicating that Precision Optics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InfuSystem
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

InfuSystem has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.61-$5.78M-$0.63N/A
InfuSystem$142.40M1.28$870K$0.3823.71

InfuSystem has a consensus price target of $15.00, indicating a potential upside of 66.48%. Given InfuSystem's stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
InfuSystem
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

InfuSystem beats Precision Optics on 13 of the 16 factors compared between the two stocks.

How does Precision Optics compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Apyx Medical presently has a consensus target price of $6.60, suggesting a potential upside of 61.25%. Given Apyx Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Apyx Medical is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Precision Optics has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$55.90M3.07-$11.21M-$0.22N/A
Precision Optics$19.09M2.61-$5.78M-$0.63N/A

In the previous week, Apyx Medical had 1 more articles in the media than Precision Optics. MarketBeat recorded 2 mentions for Apyx Medical and 1 mentions for Precision Optics. Apyx Medical's average media sentiment score of 1.24 beat Precision Optics' score of 0.75 indicating that Apyx Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Apyx Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Precision Optics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Apyx Medical has a net margin of -16.40% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-16.40% -88.47% -14.94%
Precision Optics -17.03%-37.47%-19.96%

Apyx Medical has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by company insiders. Comparatively, 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Apyx Medical beats Precision Optics on 14 of the 17 factors compared between the two stocks.

How does Precision Optics compare to Inogen?

Precision Optics (NASDAQ:POCI) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

In the previous week, Inogen had 2 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for Inogen and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.75 beat Inogen's score of 0.20 indicating that Precision Optics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inogen
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inogen has a net margin of -7.08% compared to Precision Optics' net margin of -17.03%. Inogen's return on equity of -12.90% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Inogen -7.08%-12.90%-8.27%

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by company insiders. Comparatively, 2.5% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Precision Optics has higher earnings, but lower revenue than Inogen. Precision Optics is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.61-$5.78M-$0.63N/A
Inogen$348.67M0.50-$22.75M-$0.91N/A

Precision Optics has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market. Comparatively, Inogen has a beta of 1.58, meaning that its share price is 58% more volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Summary

Inogen beats Precision Optics on 10 of the 15 factors compared between the two stocks.

How does Precision Optics compare to Avita Medical?

Precision Optics (NASDAQ:POCI) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

In the previous week, Precision Optics had 1 more articles in the media than Avita Medical. MarketBeat recorded 1 mentions for Precision Optics and 0 mentions for Avita Medical. Precision Optics' average media sentiment score of 0.75 beat Avita Medical's score of 0.57 indicating that Precision Optics is being referred to more favorably in the media.

Company Overall Sentiment
Precision Optics Positive
Avita Medical Positive

Avita Medical has a consensus price target of $7.25, indicating a potential upside of 50.35%. Given Avita Medical's stronger consensus rating and higher possible upside, analysts clearly believe Avita Medical is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Avita Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

Precision Optics has higher earnings, but lower revenue than Avita Medical. Precision Optics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.61-$5.78M-$0.63N/A
Avita Medical$72.35M2.05-$48.59M-$1.57N/A

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 14.4% of Precision Optics shares are held by company insiders. Comparatively, 2.2% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Precision Optics has a net margin of -17.03% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Avita Medical -62.67%N/A -78.92%

Precision Optics has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market.

Summary

Precision Optics and Avita Medical tied by winning 8 of the 16 factors compared between the two stocks.

Get Precision Optics News Delivered to You Automatically

Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POCI vs. The Competition

MetricPrecision OpticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$49.89M$7.14B$6.80B$12.40B
Dividend YieldN/A1.32%2.67%9.67%
P/E Ratio-7.2449.3126.9124.05
Price / Sales2.61102.92503.3491.67
Price / CashN/A26.1549.7159.37
Price / Book2.856.8810.616.19
Net Income-$5.78M$162.27M$3.60B$331.71M
7 Day Performance-3.39%-3.47%-2.02%-1.63%
1 Month Performance-15.71%-1.94%0.27%-2.17%
1 Year Performance-5.00%2.96%22.74%17.68%

Precision Optics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0.4247 of 5 stars
$4.56
+0.2%
N/A-5.4%$49.89M$19.09MN/A80
PDEX
Pro-Dex
3.764 of 5 stars
$59.08
+4.5%
$70.00
+18.5%
+20.0%$188.47M$66.59M16.32140
INFU
InfuSystem
3.3651 of 5 stars
$9.24
+2.6%
$15.00
+62.3%
+66.1%$186.48M$142.40M154.03410
APYX
Apyx Medical
3.221 of 5 stars
$4.34
-1.8%
$6.60
+52.1%
+83.9%$181.90M$55.90MN/A270
INGN
Inogen
1.5169 of 5 stars
$6.66
+3.9%
N/A+2.2%$180.35M$348.67MN/A1,030

Related Companies and Tools


This page (NASDAQ:POCI) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners